105.06

0.23% -0.165

Cvs Health Corp (CVS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CVS? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$105.22

Offen:

$105.49

24-Stunden-Volumen:

3.04M

Relative Volume:

0.38

Marktkapitalisierung:

$134.09B

Einnahmen:

$407.94B

Nettoeinkommen (Verlust:

$2.90B

KGV:

46.14

EPS:

2.2771

Netto-Cashflow:

$7.39B

1W Leistung:

-2.56%

1M Leistung:

+1.48%

6M Leistung:

+40.87%

1J Leistung:

+69.05%

1-Tages-Spanne:

$104.31

$105.77

1-Wochen-Bereich:

$103.01

$110.00

52-Wochen-Spanne:

$61.19

$110.68

Cvs Health Corp Stock (CVS) Company Profile

Firmenname

Cvs Health Corp

Sektor

Healthcare (1085)

Branche

Healthcare Plans (14)

Telefon

(401) 765-1500

Adresse

ONE CVS DR., WOONSOCKET

Mitarbeiter

300,000

Twitter

@cvshealth

Nächster Verdiensttermin

2026-08-05

Neueste SEC-Einreichungen

CVS's Discussions on Twitter

Compare CVS vs UNH, ELV, CI, HUM

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CVS Cvs Health Corp	105.09	136.61B	407.94B	2.90B	7.39B	2.2771
UNH Unitedhealth Group Inc	417.64	379.28B	450.13B	14.91B	23.62B	15.55
ELV Elevance Health Inc	377.01	82.05B	201.11B	4.95B	6.29B	22.50
CI Cigna Group	282.33	76.98B	278.13B	6.74B	7.66B	23.60
HUM Humana Inc	365.24	45.76B	137.20B	1.15B	1.27B	9.3439

Cvs Health Corp Stock (CVS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-03-12	Hochstufung	Bernstein	Mkt Perform → Outperform
2025-10-14	Eingeleitet	Goldman	Buy
2025-08-18	Hochstufung	UBS	Neutral → Buy
2025-08-14	Hochstufung	Robert W. Baird	Neutral → Outperform
2025-02-13	Hochstufung	Leerink Partners	Market Perform → Outperform
2025-02-12	Hochstufung	Cantor Fitzgerald	Neutral → Overweight
2025-01-30	Hochstufung	Edward Jones	Hold → Buy
2024-12-03	Hochstufung	Deutsche Bank	Hold → Buy
2024-11-18	Hochstufung	Wells Fargo	Equal Weight → Overweight
2024-10-10	Hochstufung	Barclays	Equal Weight → Overweight
2024-10-04	Hochstufung	TD Cowen	Hold → Buy
2024-05-30	Eingeleitet	Robert W. Baird	Neutral
2024-05-07	Herabstufung	TD Cowen	Buy → Hold
2024-05-02	Herabstufung	UBS	Buy → Neutral
2024-05-01	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2024-05-01	Herabstufung	Leerink Partners	Outperform → Market Perform
2024-03-06	Eingeleitet	Barclays	Equal Weight
2024-02-26	Eingeleitet	Leerink Partners	Outperform
2023-12-22	Eingeleitet	HSBC Securities	Buy
2023-09-19	Hochstufung	Evercore ISI	In-line → Outperform
2023-09-12	Hochstufung	Wolfe Research	Peer Perform → Outperform
2023-08-18	Herabstufung	Edward Jones	Buy → Hold
2023-05-26	Eingeleitet	Piper Sandler	Overweight
2023-04-21	Eingeleitet	Cantor Fitzgerald	Overweight
2023-01-03	Herabstufung	Evercore ISI	Outperform → In-line
2022-11-23	Fortgesetzt	Morgan Stanley	Overweight
2022-06-17	Eingeleitet	Loop Capital	Buy
2022-05-27	Herabstufung	Bernstein	Outperform → Mkt Perform
2022-03-29	Herabstufung	Deutsche Bank	Buy → Hold
2022-02-11	Herabstufung	Raymond James	Strong Buy → Outperform
2021-12-14	Eingeleitet	Goldman	Buy
2021-12-01	Eingeleitet	Seaport Research Partners	Buy
2021-05-19	Eingeleitet	Wells Fargo	Equal Weight
2021-03-17	Herabstufung	Guggenheim	Buy → Neutral
2021-01-08	Hochstufung	Jefferies	Hold → Buy
2020-09-17	Eingeleitet	Piper Sandler	Overweight
2020-07-01	Eingeleitet	SVB Leerink	Mkt Perform
2020-05-14	Hochstufung	Credit Suisse	Neutral → Outperform
2019-09-27	Fortgesetzt	RBC Capital Mkts	Outperform
2019-09-12	Eingeleitet	Deutsche Bank	Buy
2019-06-05	Hochstufung	Standpoint Research	Hold → Buy
2019-04-29	Herabstufung	Credit Suisse	Outperform → Neutral
2019-04-18	Eingeleitet	Guggenheim	Buy
2019-04-15	Herabstufung	Oppenheimer	Outperform → Perform
2019-04-10	Bestätigt	BofA/Merrill	Buy
2019-03-13	Eingeleitet	Bernstein	Outperform
2019-02-20	Herabstufung	Wells Fargo	Outperform → Market Perform
2019-01-17	Eingeleitet	UBS	Buy
2018-12-18	Eingeleitet	Barclays	Overweight
2018-11-29	Fortgesetzt	Goldman	Neutral
2018-11-28	Eingeleitet	Evercore ISI	Outperform
2018-10-26	Fortgesetzt	Wolfe Research	Peer Perform
2018-07-09	Hochstufung	Citigroup	Neutral → Buy
2018-02-27	Fortgesetzt	BofA/Merrill	Buy
2018-02-13	Bestätigt	Citigroup	Neutral

Alle ansehen

Cvs Health Corp Aktie (CVS) Neueste Nachrichten

Jul 28, 2026

Do Wall Street Analysts Like CVS Health Stock? - Barchart.com

Jul 28, 2026

The Zacks Analyst Blog Highlights CVS Health, Cardinal Health, Humana and ACADIA Pharmaceuticals - Yahoo Finance

Jul 28, 2026

Jul 27, 2026

CVS asks federal judge to consolidate four lawsuits challenging Tennessee PBM breakup law - The Business Journals

Jul 27, 2026

CVS Health stock trades steadily as investors weigh earnings trends and Medicare changes - AD HOC NEWS

Jul 25, 2026

Jul 24, 2026

CVS HEALTH CORP : UBS RAISES TARGET PRICE TO $122 FROM $115 - Bitget

Jul 24, 2026

CVS Seeks Toss Of Hospitals' 340B Suits In NY, Mich. - Law360

Jul 24, 2026

Why CVS Health (NYSE:CVS) Is Gaining Value Stock Attention? - Kalkine Media

Jul 24, 2026